Sale!

PALB2 Gene Pancreatic Cancer Type 3 Susceptibility to Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PALB2 Gene Pancreatic Cancer Type 3 Susceptibility Genetic Test is a specialized medical examination offered by DNA Labs UAE, designed to assess an individual’s genetic predisposition to developing Type 3 Pancreatic Cancer. This test specifically analyzes the PALB2 gene, which plays a crucial role in DNA repair processes. Mutations in the PALB2 gene have been associated with an increased risk of developing pancreatic cancer, among other types of cancers. By identifying variations within this gene, the test can provide valuable insights into an individual’s risk factors, potentially guiding preventive measures and personalized surveillance strategies.

The process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of specific genetic mutations in the PALB2 gene. This test is particularly recommended for individuals with a family history of pancreatic cancer or known genetic predispositions, as it can offer early warnings and facilitate proactive health management.

The cost of the PALB2 Gene Pancreatic Cancer Type 3 Susceptibility Genetic Test at DNA Labs UAE is set at 4400 AED. Given the complexity of the analysis and the potential life-saving insights it can provide, many consider it a valuable investment in their health and well-being.

Description

PALB2 Gene Pancreatic Cancer Type 3 Susceptibility to Genetic Test

Test Name: PALB2 Gene Pancreatic Cancer Type 3 Susceptibility to Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cancer

Doctor: Oncologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for PALB2 Gene Pancreatic Cancer Type 3, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PALB2 Gene Pancreatic Cancer Type 3, susceptibility to NGS Genetic DNA Test gene PALB2.

Test Details: The PALB2 gene is a tumor suppressor gene that plays a role in repairing damaged DNA. Mutations in the PALB2 gene have been associated with an increased risk of developing pancreatic cancer. NGS (Next-Generation Sequencing) is a type of genetic testing that allows for the simultaneous sequencing of multiple genes or the entire exome (all the protein-coding regions of genes) in a person’s DNA. NGS can identify specific mutations or genetic variants in the PALB2 gene that may increase an individual’s susceptibility to pancreatic cancer type 3. Pancreatic cancer type 3 refers to a specific subtype of pancreatic cancer, which may have different characteristics or treatment options compared to other subtypes. By undergoing NGS genetic testing, individuals can determine if they carry any mutations or variants in the PALB2 gene that may increase their risk of developing pancreatic cancer type 3. This information can be valuable for both individuals and their healthcare providers in making informed decisions about screening, prevention, and treatment options.

Test Name	PALB2 Gene Pancreatic cancer type 3 susceptibility to Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Cancer
Doctor	Oncologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for PALB2 Gene Pancreatic cancer type 3, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PALB2 Gene Pancreatic cancer type 3, susceptibility to NGS Genetic DNA Test gene PALB2
Test Details	The PALB2 gene is a tumor suppressor gene that plays a role in repairing damaged DNA. Mutations in the PALB2 gene have been associated with an increased risk of developing pancreatic cancer. NGS (Next-Generation Sequencing) is a type of genetic testing that allows for the simultaneous sequencing of multiple genes or the entire exome (all the protein-coding regions of genes) in a person’s DNA. NGS can identify specific mutations or genetic variants in the PALB2 gene that may increase an individual’s susceptibility to pancreatic cancer type 3. Pancreatic cancer type 3 refers to a specific subtype of pancreatic cancer, which may have different characteristics or treatment options compared to other subtypes. By undergoing NGS genetic testing, individuals can determine if they carry any mutations or variants in the PALB2 gene that may increase their risk of developing pancreatic cancer type 3. This information can be valuable for both individuals and their healthcare providers in making informed decisions about screening, prevention, and treatment options.